HPLC determination of oxidized and reduced pyridine coenzymes in human erythrocytes.
The nucleotide concentrations in acid and alkaline erythrocyte extracts have been measured by RP-HPLC in healthy controls and in patients bearing different inherited disorders, with altered erythrocyte NAD(P) levels. The objective was the simultaneous determination of the nucleotide profile and of the oxidative state of pyridine coenzymes by the most suitable extraction method. Both alkaline and acid extractions were necessary to obtain the complete pattern, due to defective recovery of the oxidized or reduced coenzymes, respectively, during the extraction procedures. Purine nucleotide quantification seemed to be reliable by all methods. High NADP+ levels were confirmed in two glucose-6-phosphate dehydrogenase deficient patients, coupled with raised NAD levels, lowered NADPH/NADP+ ratio and increased NADH/NAD+ ratio. Higher NAD+ and normal or lower NADH/NAD+ ratios were found in two hypoxanthine-phosphoribosyltransferase deficient patients, while a patient with superactive phosphoribosylpyrophosphate synthetase showed a decreased NADH level in addition to the low NAD+ level previously found.
Micheli
V
V
Dipartimento di Biologia Molecolare, Università di Siena, Italy.
Simmonds
H A
HA
Bari
M
M
Pompucci
G
G
D002851:Chromatography, High Pressure Liquid; D004912:Erythrocytes / Q000737:chemistry*; D005953:Glycogen Storage Disease Type I / Q000097:blood; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000097:blood; D009243:NAD / Q000097:blood* / Q000302:isolation & purification; D009249:NADP / Q000097:blood* / Q000302:isolation & purification; D010084:Oxidation-Reduction; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency; D012268:Ribose-Phosphate Pyrophosphokinase / Q000378:metabolism
D009243:NAD; D009249:NADP; D011683:Purine-Nucleoside Phosphorylase; D012268:Ribose-Phosphate Pyrophosphokinase